NATCO PHARMA LTD FDA Approval ANDA 077851

ANDA 077851

NATCO PHARMA LTD

FDA Drug Application

Application #077851

Application Sponsors

ANDA 077851NATCO PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 4MG BASE0ONDANSETRON HYDROCHLORIDEONDANSETRON HYDROCHLORIDE
002TABLET;ORALEQ 8MG BASE0ONDANSETRON HYDROCHLORIDEONDANSETRON HYDROCHLORIDE

FDA Submissions

ORIG1AP2007-06-25
LABELING; LabelingSUPPL2AP2014-12-31STANDARD
LABELING; LabelingSUPPL3AP2014-12-31STANDARD
LABELING; LabelingSUPPL5AP2017-02-14STANDARD

Submissions Property Types

SUPPL1Null15
SUPPL2Null7
SUPPL3Null7
SUPPL5Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

NATCO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77851
            [companyName] => NATCO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"ONDANSETRON HYDROCHLORIDE","activeIngredients":"ONDANSETRON HYDROCHLORIDE","strength":"EQ 4MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ONDANSETRON HYDROCHLORIDE","activeIngredients":"ONDANSETRON HYDROCHLORIDE","strength":"EQ 8MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ONDANSETRON HYDROCHLORIDE","submission":"ONDANSETRON HYDROCHLORIDE","actionType":"EQ 4MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ONDANSETRON HYDROCHLORIDE","submission":"ONDANSETRON HYDROCHLORIDE","actionType":"EQ 8MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.